Hypomethylating Agents and the Treatment of MDS

adicionou um novo artigo Health

2026-11-10 03:51:19 - Traduzir -

Myelodysplastic syndromes are a group of blood cancers where the bone marrow fails to produce healthy blood cells. Treatment options are limited—especially for older patients. Hypomethylating agents like decitabine offer a valuable option, and their role is shaping the decitabine drug market. Within the Decitabine Drug Market, MDS is a major application. The commercial implications favor...

0 Comentários 0 Compartilhamentos 2 Visualizações 0 Anterior